Article
Minireview: Were the IGF Signaling Inhibitors All Bad?
14 Sept 2015
Abstract excerpt
Preclinical studies in the 1980s defined a role for IGF signaling in the development and sustainability of the malignant process. Subsequently, antibody, tyrosine kinase, and ligand inhibitors of the IGF receptor were manufactured. In the past decade, numerous clinical trials have tested the efficacy of IGF receptor inhibitors in the treatment of advanced tumors. Early-phase trials in heavily pretreated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
